Metformin + Glyburide is a prescription medication that combines two oral antidiabetic agents for the treatment of type 2 diabetes. It is formulated as a single tablet that delivers both active ingredients in fixed proportions to improve blood glucose control. The drug works by lowering hepatic glucose production and increasing peripheral insulin sensitivity. Metformin reduces hepatic gluconeogenesis and enhances insulin mediated glucose uptake in muscle tissue. Glyburide stimulates pancreatic beta cells to release more insulin, thereby raising circulating insulin levels. Together they address insulin resistance and beta cell dysfunction, leading to decreased fasting and postprandial glucose concentrations. The medication ultimately improves glycemic control by decreasing the liver's release of glucose and increasing the body's response to endogenous insulin. Its therapeutic effect results from the synergistic action of the two agents on glucose metabolism pathways.

Metformin + Glyburide is a prescription combination used to improve blood sugar control in type 2 diabetes. Metformin belongs to the biguanide class and reduces hepatic glucose production by inhibiting gluconeogenesis. It also decreases intestinal absorption of glucose and enhances peripheral insulin sensitivity through activation of the amp-activated protein kinase pathway. Glyburide is a sulfonylurea that binds to the pancreatic k-atp channel on beta cells, leading to closure of the channel and an influx of calcium that triggers insulin release. Together they target complementary pathways, allowing lower doses of each drug while achieving consistent glycemic lowering. The biochemical sequence therefore involves suppression of liver glucose output and stimulation of pancreatic insulin secretion. This coordinated pharmacology underlies the therapeutic effect of improving overall glucose homeostasis without directly affecting insulin receptor signaling.

Metformin may cause gastrointestinal discomfort such as nausea or diarrhea. Glyburide can lead to low blood sugar levels resulting in dizziness or weakness. Both drugs sometimes cause headaches that are usually mild. Metformin occasionally produces a metallic taste in the mouth. Glyburide may increase the risk of skin rash or itching. Some people experience mild swelling in the hands or feet. These effects are generally temporary and often improve with continued use.

Metformin commonly causes nausea and diarrhea when first taken. It may also lead to a metallic taste or mild abdominal discomfort. Glyburide frequently produces low blood sugar episodes manifesting as dizziness or sweating. Both agents can cause headache and fatigue as early reactions. Prolonged use of metformin may result in reduced vitamin b12 levels over time. Combining the two medications can increase the risk of hypoglycemia compared with either drug alone.